Carbon Dioxide is Good for the Planet
3 April 2025
How I Blew Grok’s Mind
2 April 2025
by Andy A West
Today we're publishing an original piece by Dr Alan Mordue, a retired public health consultant, about the risk to young people of being vaccinated against COVID-19. He thinks healthy people under 50 shouldn't have the jab.
Is the Yellow Card vaccine reporting system fit for purpose? HART's Dr Ros Jones argues no, pointing to the 30-fold increase in vaccine linked deaths in the U.S in the past 3 months since Covid vaccination began.
If the Government still has confidence in the vaccines then it needs to act like it. If it doesn't then it needs to be upfront about this so a proper debate can be had about what that means for the future.
AstraZenaca is no worse than other vaccines when it comes to cerebral venous thrombosis, according to new preprint. CVT more likely to be caused by Covid.
Has Boris lost his faith in the vaccines? That's certainly the impression you'd get from what he has said this morning. But he is wrong to claim that infections have fallen mainly because of the lockdown.
Now is the time to return to normal, just as a number of states in America have done and seen no catastrophe. It is not the time to think we can create a 100% effective barrier against a seasonal respiratory disease.
An Oxford University study has confirmed the remarkable effectiveness of common asthma treatment Budesonide for treating COVID-19, reducing the risk of serious disease by 90% if taken at an early stage.
Following yesterday's news about the pro-vaccination ruling in the European Court of Human Rights, we asked David McGrogan, Associate Professor of Law at Northumbria Law School, to take a look at the judgment for us.
The latest cautionary tale being held up to locked down Britons as the reason we can't be released is Chile, where an ambitious vaccination programme has not prevented a new surge. But is all as it seems?
A new study – the largest of its kind – has found that the Pfizer vaccine produces an "off the scale" immune response likely to protect against the Brazilian, Kent and Wuhan variants.
© Skeptics Ltd.